Earnings Outlook For Amphastar Pharma
Portfolio Pulse from Benzinga Insights
Amphastar Pharma (NASDAQ:AMPH) is scheduled to release its quarterly earnings report on February 28, 2024. Analysts predict an EPS of $0.91. Historical data shows significant stock price movements following earnings announcements, with a 15.39% increase after last quarter's beat. Shares are currently trading at $55.09, up 52.63% over the last year. Investors are optimistic but will focus on both the earnings outcome and the company's future guidance.
February 27, 2024 | 3:01 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Amphastar Pharma is expected to report an EPS of $0.91 for the upcoming quarter. Historical performance shows significant price movements post-earnings, with a notable 15.39% increase after the last beat. Shares have risen 52.63% over the past year, indicating strong investor confidence.
Given Amphastar Pharma's history of significant stock price movements following earnings beats and the current positive trend in its share price, there is a strong likelihood of a positive short-term impact on AMPH's stock price if the company meets or exceeds the EPS estimate and provides optimistic future guidance.
CONFIDENCE 85
IMPORTANCE 90
RELEVANCE 100